fda warning letter compounding pharmacy bpc-157 issued 25 letters to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of February 17, 2026: Pennsylvania compounding
February 17, 2026: Pennsylvania compounding pharmacy earns another FDA warning letter Partnership for Safe Medicines Compounding warning letters to 503A facilities between 2017 and 2021 ScienceDirect FDA Warns 25 Firms Over Compounded GLP 1 Claims Warning Letter IPQ
Pay in 4 interest-free payments of $6.78 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22



